Long-term survival projections of loncastuximab tesirine-treated patients in relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).Mehdi Hamadani,Christopher N. Graham,Laura Liao, Katherine H. Zhang,Hannah Strat,David Ungar,Weiyun Z. Ai,Lei Chen,Carmelo Carlo-StellaHemaSphere(2022)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要